Matthias Meier

Specialty unconfirmed

Novartis Pharma AG

Switzerland.

Last updated· April 2026 5 publications

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

C3 glomerulopathy

Verify independently

PubMed author search

Other specialists for C3 glomerulopathy

Peers ranked by clinical-trial PI role, publications, and verification quality.

Richard J H Smith
Carver College of Medicine
Marina Vivarelli
Bambino Gesù Pediatric Hospital IRCCS
Fernando Caravaca-Fontán
Instituto de Investigación Hospital 12 de Octubre
Manuel Praga
Complutense University
Nicholas J A Webb
Novartis Institutes for BioMedical Research
IN
Andrew S Bomback, M.D
Columbia University Irving Medical Center
NY
Giuseppe Remuzzi
Clinical Research Center for Rare Diseases "Aldo e Cele Daccò"
Moglie Le Quintrec
Centre Hospitalier Universitaire de Montpellier

See all specialists for C3 glomerulopathy →

← Back to specialists directory